Investigating Novel Immunotherapy Combinations for Advanced Gastric and Esophageal Cancers | Docwire News
Dr. Cytryn summarizes a trial in progress investigating a novel immunotherapy combination for gastroesophageal adenocarcinoma
Dr. Cytryn summarizes a trial in progress investigating a novel immunotherapy combination for gastroesophageal adenocarcinoma
At ASCO GU 2025, researchers presented efficacy and safety findings from the EPIC-A trial of cemiplimab with SOC chemotherapy.
Sacituzumab govitecan “demonstrated promising efficacy” as a second-line therapy for extensive-stage small cell lung cancer (ES-SCLC), regardless of platinum sensitivity.
The European Association of Urology (EAU) Paediatric Urology Guidelines Panel has prepared these Guidelines with the aim of increasing the quality of care for children…
Robert E. Merritt, MD, MBA, FACS, discusses the importance of patient selection and adhering to oncologic principles when utilizing sublobar resection to treat early-stage NSCLC.
With a plethora of exciting activities, including Showcase presentations, reverse pitches, and mentorship opportunities, attendees have the opportunity to expand their knowledge and connect with…
Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys.
Proposed changes to HIPAA regulations are meant to strengthen cybersecurity protections for electronic protected health information.
“What we’re really trying to see now is this integration of imaging and using it with respect to AI and planning,” says Dean S. Elterman,…
“Taken altogether, the study remains positive for PFS, but not for overall survival,” says Laurence Albiges, MD, PhD.
The Prostate Cancer (PCa) Guidelines Panel have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa.